FUJIFILM Diosynth Biotechnologies vs Pfizer CentreOne: CDMO Comparison

Side-by-side comparison of FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score
84/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
12
MHRA GMP certificates (compliant)
6
Clinical programs (matched)
0
Capacity
Expanding
Modalities
AAV, mRNA/LNP, Biologics
Kalamazoo, MI · McPherson, KS
Signal Score
92/100
Quality (FDA + GMP)
100/100
FDA inspections
4
— NAI / VAI / OAI
3 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
14
MHRA GMP certificates (compliant)
3
Clinical programs (matched)
366
Capacity
Modalities
Biologics, mRNA

Key differences

  • Pfizer CentreOne has more FDA inspections on record (4 vs 0) — a deeper regulatory paper trail.
  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Pfizer CentreOne appears as a manufacturing partner on more matched clinical programs (366 vs 0) — a broader sponsor book.

On a 13-modality CDMO landscape, both FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne qualify as mRNA/LNP manufacturers; Pfizer CentreOne carries the higher composite Signal Score for mRNA/LNP programs in this comparison.

What to evaluate for mRNA/LNP programs

Both FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

IVT mRNA synthesis

Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.

LNP formulation

LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.

Plasmid / starting material

mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.

Cold chain & stability

mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.

See all mRNA/LNP CDMOs ranked by Signal Score →

Frequently asked: FUJIFILM Diosynth Biotechnologies vs Pfizer CentreOne

Which has the stronger FDA inspection record, FUJIFILM Diosynth Biotechnologies or Pfizer CentreOne?

Both FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. FUJIFILM Diosynth Biotechnologies has 0 FDA inspections on record; Pfizer CentreOne has 4.

How do FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne compare on European GMP coverage?

FUJIFILM Diosynth Biotechnologies holds 12 active EMA GMP certificates and 6 MHRA / UK certificates. Pfizer CentreOne holds 14 active EMA GMP certificates and 3 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — FUJIFILM Diosynth Biotechnologies or Pfizer CentreOne?

FUJIFILM Diosynth Biotechnologies is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Pfizer CentreOne is matched to 366. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

Which is better for mRNA/LNP manufacturing — FUJIFILM Diosynth Biotechnologies or Pfizer CentreOne?

Both FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

FUJIFILM Diosynth Biotechnologies carries a Signal Score of 84/100 and Pfizer CentreOne carries 92/100 — a small lead for Pfizer CentreOne. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating FUJIFILM Diosynth Biotechnologies and Pfizer CentreOne for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.